Kathy S Albain
8PUBLICATIONS
112CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (8)
Sort by Publication Date:
|Dec 02, 2024
Development and Validation of the RSClinN+ Tool to Predict Prognosis and Chemotherapy Benefit for Hormone Receptor-Positive, Node-Positive Breast Cancer.Lajos Pusztai, Jess R Hoag, Kathy S Albain
|Jun 27, 2024
Adjuvant Trastuzumab Emtansine Versus Paclitaxel Plus Trastuzumab for Stage I Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: 5-Year Results and Correlative Analyses From ATEMPT.Paolo Tarantino, Nabihah Tayob, Guillermo Villacampa
|May 30, 2024
Pre-treatment amino acids and risk of paclitaxel-induced peripheral neuropathy in SWOG S0221.Ciao-Sin Chen, Gary Zirpoli, G Thomas Budd
|Dec 18, 2023
Neoadjuvant Trebananib plus Paclitaxel-based Chemotherapy for Stage II/III Breast Cancer in the Adaptively Randomized I-SPY2 Trial-Efficacy and Biomarker Discovery.Kathy S Albain, Christina Yau, Emanuel F Petricoin
|Aug 24, 2023
Effects of CYP3A4 and CYP2C9 genotype on systemic anastrozole and fulvestrant concentrations in SWOG S0226.Delaney V Rutherford, Sarah Medley, Nicholas C Henderson
|Jan 17, 2023
Evaluation of the Sensitivity to Endocrine Therapy Index and 21-Gene Breast Recurrence Score in the SWOG S8814 Trial.Corey W Speers, W Fraser Symmans, William E Barlow
Pageof 2
Frequent Collaborators
5 joint publications
Lajos Pusztai
4 joint publications
Gabriel N Hortobagyi
4 joint publications
William E Barlow
3 joint publications
James M Rae
3 joint publications
Hope S Rugo
3 joint publications
N Lynn Henry
3 joint publications
Rita Nanda
2 joint publications
Nabihah Tayob
2 joint publications
Ron Bose
2 joint publications
Antonio C Wolff
